• 호남수학학술지
• /
• 제34권1호
• /
• pp.85-92
• /
• 2012

Our purpose of this paper is to introduce and study some properties related to approximations by points. More precisely, we introduce strongly AP, strongly AFP, strongly ACP, and strongly WAP properties which are stronger than AP, AFP, ACP, and WAP respectively. Also they are weaker than strongly Fr$\acute{e}$chet property. And we study general properties and topological operations on such spaces and give some examples.

• Reproductive and Developmental Biology
• /
• 제34권3호
• /
• pp.135-141
• /
• 2010

Embryoid bodies (EBs) generated from human embryonic stem cells (hESCs) include spontaneously induced endodermal lineage cells (ELCs). Activin-A plays important roles in the endoderm differentiation of hESCs. Despite studies on the generation of ELCs from hESCs with treatment of Actvin-A, it was unclear for localization and pattern of ELCs by Activin-A during differentiation of hESCs. Accordingly in this study, we knew that Actvin-A increased the cystic EBs formation, including the highly enriched AFP (endoderm lineage specific marker)-expressing cells in the surface of cystic EBs. To induce the EBs formation from undifferentiated hESCs, cells were transferred onto petri-dish and cultured in suspension condition without bFGF removed hESC media (EB media) for 3 days. Next to investigate the effect of Activin-A, EBs were subsequently cultured in EB media supplement with 100 ng/ml Activin-A for 3 days. After 5~7 days of Activin-A treatment, cystic EBs began to appear which increased in numbers reaching ~60% of initially formed EBs over 5 days. Endoderm lineage marker, AFP were highly expressed and specifically localized at the surface region of cystic EBs comparison with normal EBs. We next attached the cystic EBs onto gelatin-coated plates and cultured for 5 days. In the results of real-time PCR and immunocytochemistry analysis, AFP-expressing cells migrated and localized at the outgrowth region of attached cystic EBs. To obtain the AFP-expressing cells of the outgrowth region, we manually isolated by using micro-dissection and cultured them. These cells strongly express AFP over 70% of isolated cells post re-plating. Here, we first showed an expression pattern of specifically localized ELCs by Activin-A during differentiation of hESCs. From this observation, we could highly purified ELCs from undifferentiated hESCs. Taken together, our system will provide a novel and efficient option to generate ELCs from hESCs.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권7호
• /
• pp.2979-2986
• /
• 2014

Background: Recently, peroxiredoxin3 (PRDX3) was identified as a novel molecular marker for the progression of hepatocellular carcinoma (HCC). However, its potential clinical application as a serum marker for the early diagnosis and prognosis of HCC has not been investigated. Methods: PRDX3, alpha-fetaprotein (AFP), and other biochemical parameters were measured in serum samples from 297 Chinese patients, including 96 with HCC, 98 with liver cirrhosis (LC), and 103 healthy controls (HCs). Correlations between serum PRDX3 expression and clinicopathological variables and the relationship between serum PRDX3 expression and prognosis were analyzed. Results: Serum PRDX3 was significantly higher in HCC patients than in the LC and HC groups. The sensitivity and specificity of serum PRDX3 for the diagnosis of HCC were 85.9% and 75.3%, respectively, at a cutoff of 153.26 ng/mL, and the area under the curve was 0.865. Moreover, serum PRDX3 expression was strongly associated with AFP level, tumor diameter, TNM stage, and portal vein invasion. Kaplan-Meier curve analysis revealed that HCC patients with high serum PRDX3 expression had a shorter median survival time than those with low PRDX3 expression. Moreover, serum PRDX3 expression was an independent risk factor for overall survival. The inverse correlation between serum PRDX3 and patient survival remained significant in patients with early-stage HCC and in those with normal serum AFP levels. Conclusions: Serum PRDX3 can be used as a noninvasive biomarker for the diagnosis and/or prognosis of HCC.

• 원예과학기술지
• /
• 제34권6호
• /
• pp.886-897
• /
• 2016

공정육묘장들이 계절별 기상환경에 적합하도록 혼합상토의 조성을 변화시키고 있다. 본 연구는 계절별(하절기, 동절기, 봄 가을) 육묘에 적합한 상토를 선발하기 위해 수행되었다. 실험을 위해 다양한 국가에서 수입된 8종류의 피트모스와 입경이 다른 4종류의 펄라이트를 수집한 후 비율을 피트모스 7: 펄라이트3(v/v)으로 고정시킨 32종류의 상토를 만들었다. 이 후 공극률, 기상률 및 액상률의 삼상분포, 그리고 pH, EC 및 무기물 함량 등 화학성을 분석한 후 6종류 상토를 선발하였다. 선발 된 상토를 대상을 추가로 쉽게 이용할 수 있는 수분량(EAW)과 완충수분(BW), cation exchange capacity(CEC) 그리고 각종 화학성을 분석하여 기비 혼합을 위한 판단기준으로 삼았다. 피트모스와 펄라이트를 혼합한 상토는 공극률 64.7-96.0%, 용기용 수량 42.9-90.1%, 그리고 기상률이 1.3-27.8%의 범위로 측정되었고, 혼합되는 피트모스와 펄라이트 종류에 따라 물리성의 차이가 컸다. 피트모스의 pH와 EC가 각각 2.96-3.81 및 $0.08-0.47dS{\cdot}m^{-1}$로 분석되었지만 펄라이트를 혼합한 후 pH가 상승하고 EC가 낮아졌다. 하절기용으로 선발한 Blonde Golden peatmoss(BG) + 펄라이트(입경 1mm 이하) 1호(PE1)와 Latagro 10mm 이하(L1) + 펄라이트(1-2mm) 2호(PE2) 상토는 공극률, 용기용수량 및 기상률이 각각 89.8-90.9, 80.8-81.3 및 9.0-9.7%였다. 동절기용으로 선발한 Sfagnumi Turvas(ST) + PE2와 Laragro 20-40mm(L3) + PE2 상토는 이들 세 종류 항목이 각각 79.9-86.7, 60.4-74.9 및 11.8-19.6% 그리고 봄 가을용인 BG + 펄라이트 2-5mm(PE3)와 Orange peatmoss(O) + PE3이 각각 85.2-87.3, 77.9 및 7.4-9.4%이었다. EAW는 봄 가을과 하절기용이 각각 24.2-24.9%, 22.0-28.6%의 범위였지만 동절기용은 각각 18.0-21.8%로 측정되었으며, BW는 계절별로 선발한 상토에 따른 차이가 뚜렷하지 않았다. 선발된 6종류 혼합상토의 pH는 3.11-3.97, EC는 $0.06-0.26dS{\cdot}m^{-1}$, 그리고 양이온치환용량은 $97-119meq{\cdot}100g^{-1}$ 범위에 포함되었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권2호
• /
• pp.747-752
• /
• 2013

Oncostatin M (OSM) is a multifunctional cellular regulator acting on a wide variety of cells, which has potential roles in the regulation of gene activation, cell survival, proliferation and differentiation. Previous studies have shown that OSM can induce morphological and/or functional differentiation and maturation of many tumor cells. However, the action of OSM on the induction of differentiation of human hepatocellular carcinoma (HCC) has not been reported. Here, we investigated the effects of different concentrations of OSM on human HCC cell line SMMC-7721 growth, proliferation, cell cycling, apoptosis and differentiation in vitro. Cell growth was determined via MTT assay, proliferation by cell cycle analysis, apoptosis by flow cytometry, morphology by transmission electronic microscopy, and cell function by detection of biochemical markers. Our results demonstrated that OSM strongly inhibited the growth of SMMC-7721 cells in a dose-dependent manner, associated with decreased clonogenicity. Cell cycle analysis revealed a decreased proportion of cells in S phase, with arrest at G0/G1. The apotosis rate was increased after OSM treatment compared to the control. These changes were associated with striking changes in cellular morphology, toward a more mature hepatic phenotype, accompanied by significant reduction of the expression of AFP and specific activity of ${\gamma}$-GT, with remarkable increase in secretion of albumin and ALP activity. Taken together, our findings indicate that OSM could induce the differentiation and reduce cell viability of SMMC-7721 cells, suggesting that differentiation therapy with OSM offers the opportunity for therapeutic intervention in HCC.